Literature DB >> 26443700

Fixed ratio or lower limit of normal for the FEV1 /VC ratio: relation to symptoms and extended lung function tests.

Per Wollmer1, Sophia Frantz1, Gunnar Engström2, Magnus Dencker1, Claes-Göran Löfdahl3, Ulf Nihlén3.   

Abstract

There is no general agreement on the spirometric definition of chronic obstructive pulmonary disease (COPD). The global initiative for obstructive lung disease recommends a fixed ratio between forced expiratory volume in one-second (FEV1 ) and forced vital capacity (FVC) of <0·7 (FR) for the diagnosis of COPD. European Respiratory Society and American Thoracic Society favour the use of the fifth percentile of the age-related FEV1 /FVC ratio (the lower limit of normal, LLN). The purpose of this study was to analyse extensive lung function tests in groups of subjects fulfilling none, either or both of the spirometric criteria for COPD. From a previous population-based study, 450 subjects were examined with spirometry, body pletysmography diffusing capacity for CO (DL,CO ), Impulse Oscillometry System (IOS) and answered a questionnaire on respiratory symptoms and diseases. Seventy subjects fulfilled both spirometric COPD criteria (FR+LLN+), 62 subjects the fixed ratio criterion (FR+) only. Of the remaining 318 subjects, 236 were ever smokers (N-ES). Significant differences between all groups were seen for FEV1 and DL,CO . Significant differences between groups were also seen for residual volume (RV) and RV/total lung capacity. For IOS, variables and symptoms increasingly abnormal values were seen from never smokers to FR+LLN+. This study shows that subjects meeting both spirometric COPD criteria frequently have symptoms and findings at extended lung function tests compatible with the diagnosis. Also subjects meeting the fixed ratio criterion only tend to have more symptoms and lung function findings compatible with COPD than ever-smoking subjects with FEV1 /VC > 0·7.
© 2015 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Impulse Oscillometry System; chronic obstructive pulmonary disease; diagnosis; diffusing capacity for CO; spirometry

Mesh:

Year:  2015        PMID: 26443700     DOI: 10.1111/cpf.12294

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  4 in total

1.  Lung function reductions associated with motor vehicle density in chronic obstructive pulmonary disease: a cross-sectional study.

Authors:  Monika Nitschke; Sarah L Appleton; Qiaoyu Li; Graeme R Tucker; Pushan Shah; Peng Bi; Dino L Pisaniello; Robert J Adams
Journal:  Respir Res       Date:  2016-10-24

2.  High prevalence of undiagnosed COPD among patients evaluated for suspected myocardial ischaemia.

Authors:  Andreas Jönsson; Artur Fedorowski; Gunnar Engström; Per Wollmer; Viktor Hamrefors
Journal:  Open Heart       Date:  2018-10-25

3.  Matrix Metalloproteinases in COPD and atherosclerosis with emphasis on the effects of smoking.

Authors:  M Kraen; S Frantz; U Nihlén; G Engström; C G Löfdahl; P Wollmer; M Dencker
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

4.  Efficacy of guided self-change for smoking cessation in chronic obstructive pulmonary disease patients: A randomized controlled clinical trial.

Authors:  Mehran Zarghami; Fatemeh Taghizadeh; Ali Sharifpour; Abbas Alipour
Journal:  Tob Induc Dis       Date:  2019-12-11       Impact factor: 2.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.